Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2016, Article ID 6373706, 8 pages
http://dx.doi.org/10.1155/2016/6373706
Case Report

Erythrocytosis due to PHD2 Mutations: A Review of Clinical Presentation, Diagnosis, and Genetics

1Chicago Medical School, North Chicago, IL, USA
2Little Company of Mary Hospital, Evergreen Park, IL, USA

Received 8 November 2015; Revised 8 February 2016; Accepted 10 February 2016

Academic Editor: Stephen Langabeer

Copyright © 2016 Rachel Wilson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Berra, E. Benizri, A. Ginouvès, V. Volmat, D. Roux, and J. Pouysségur, “HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia,” The EMBO Journal, vol. 22, no. 16, pp. 4082–4090, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Percy, Q. Zhao, A. Flores et al., “A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 3, pp. 654–659, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Percy, P. W. Furlow, P. A. Beer, T. R. J. Lappin, M. F. McMullin, and F. S. Lee, “A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove,” Blood, vol. 110, no. 6, pp. 2193–2196, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. P. H. Maxwell, G. U. Dachs, J. M. Gleadle et al., “Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 15, pp. 8104–8109, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Hu, A. Dai, and S. Tan, “Hypoxia-inducible factor 1 alpha upregulates the expression of inducible nitric oxide synthase gene in pulmonary arteries of hypoxic rat,” Chinese Medical Journal, vol. 115, no. 12, pp. 1833–1837, 2002. View at Google Scholar · View at Scopus
  6. C. Ladroue, D. Hoogewijs, S. Gad et al., “Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia,” Haematologica, vol. 97, no. 1, pp. 9–14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. McMullin, “Idiopathic erythrocytosis: a disappearing entity,” Hematology/the Education Program of the American Society of Hematology, vol. 2009, no. 1, pp. 629–635, 2009. View at Publisher · View at Google Scholar
  8. C. Yang, Z. Zhengping, S. Fliedner, U. Shankavaram, M. Sun, and P. Bullova, “Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia,” Journal of Molecular Medicine, vol. 93, no. 1, pp. 93–104, 2015. View at Google Scholar
  9. E. R. Maher, H. P. H. Neumann, and S. Richard, “Von Hippel-Lindau disease: a clinical and scientific review,” European Journal of Human Genetics, vol. 19, no. 6, pp. 617–623, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. N. J. Mabjeesh and S. Amir, “Hypoxia-inducible factor (HIF) in human tumorigenesis,” Histology and Histopathology, vol. 22, no. 5, pp. 559–572, 2007. View at Google Scholar · View at Scopus
  11. C. Yang, M. G. Sun, J. Matro et al., “Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas,” Blood, vol. 121, no. 13, pp. 2563–2566, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Ladroue, R. Carcenac, M. Leporrier et al., “PHD2 mutation and congenital erythrocytosis with paraganglioma,” The New England Journal of Medicine, vol. 359, no. 25, pp. 2685–2692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Lee, J. D. Lynd, S. O'Reilly, M. Kiupel, J. J. McCormick, and J. J. LaPres, “The biphasic role of the hypoxia-inducible factor prolyl-4-hydroxylase, PHD2, in modulating tumor-forming potential,” Molecular Cancer Research, vol. 6, no. 5, pp. 829–842, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Mamlouk, J. Kalucka, R. P. Singh et al., “Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development,” International Journal of Cancer, vol. 134, no. 4, pp. 849–858, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. McDonough, V. Li, E. Flashman et al., “Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2),” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 26, pp. 9814–9819, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Albiero, M. Ruggeri, S. Fortuna et al., “Analysis of the oxygen sensing pathway genes in familial chronic myeloproliferative neoplasms and identification of a novel EGLN1 germ-line mutation,” British Journal of Haematology, vol. 153, no. 3, pp. 405–408, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Al-Sheikh, K. Moradkhani, M. Lopez, H. Wajcman, and C. Préhu, “Disturbance in the HIF-1α pathway associated with erythrocytosis: further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene,” Blood Cells, Molecules, and Diseases, vol. 40, no. 2, pp. 160–165, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Albiero, M. Ruggeri, S. Fortuna et al., “Isolated erythrocytosis: study of 67 patients and identification of three novel germ-line mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene,” Haematologica, vol. 97, no. 1, pp. 123–127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Bento, M. J. Percy, B. Gardie et al., “Genetic basis of congenital erythrocytosis: mutation update and online databases,” Human Mutation, vol. 35, no. 1, pp. 15–26, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-H. Jang, J. Y. Seo, J. Jang et al., “Hereditary gene mutations in Korean patients with isolated erythrocytosis,” Annals of Hematology, vol. 93, no. 6, pp. 931–935, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Bento, H. Almeida, T. M. Maia et al., “Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (where is/are the missing gene(s)?),” European Journal of Haematology, vol. 91, no. 4, pp. 361–368, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Gardie, M. J. Percy, D. Hoogewijs et al., “The role of PHD2 mutations in the pathogenesis of erythrocytosis,” Hypoxia, vol. 2014, no. 2, pp. 71–90, 2014. View at Publisher · View at Google Scholar